GLP-1 transformation claims: what the science says about 'glow-ups'

What did @itskatma actually say?

Technically? Nothing. The transcript is entirely song lyrics, specifically the repeated line "never ever met her at all" overlaid on what appears to be a before-and-after transformation video. There are zero spoken health claims in this content. The video communicates its message entirely through visuals and the hashtags transformation, glowup, and beforeandafter.

That's worth pausing on. A video with 1.8 million views about apparent physical transformation delivers its entire narrative without a single sentence about how it happened. The implication is obvious. The absence of explicit claims is not the same as the absence of influence. Viewers draw their own conclusions, and in the GLP-1 category, those conclusions tend to be specific.

Does the science back this up?

Since there are no verbal claims to evaluate, we have to assess what the format itself implies. Before-and-after transformation content, particularly content tagged in the GLP-1 ecosystem, consistently implies rapid, dramatic weight loss achievable through medication. Some of that implication is accurate. Some of it is dangerously incomplete.

GLP-1 receptor agonists like semaglutide and tirzepatide do produce meaningful weight loss in clinical trials. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found tirzepatide produced up to 22.5% body weight reduction over 72 weeks in adults with obesity. The STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide at 2.4mg produced roughly 14.9% weight reduction. These are real, significant numbers. Transformation content isn't lying about the category of effect.

What it omits is the full picture: side effect profiles, the reality of weight regain after discontinuation (Wilding et al., 2022, Diabetes, Obesity and Metabolism found most weight returned within a year of stopping semaglutide), and the fact that individual results vary enormously depending on baseline health, adherence, and lifestyle factors.

What did they get wrong (or right)?

Without spoken claims, there's nothing technically wrong or right in the transcript. But format is a kind of argument, and this format has known problems.

Before-and-after content in this category routinely sets unrealistic expectations. A 2023 analysis in the Journal of Medical Internet Research (Crabb et al.) found that GLP-1-adjacent social media content disproportionately featured rapid transformations while underrepresenting side effects, cost barriers, and the chronic nature of obesity as a disease. Viewers exposed to this content showed inflated expectations about treatment timelines.

To be fair to @itskatma, the video makes no false promises. There's no "lost 40 pounds in 6 weeks" claim, no dosing advice, no product recommendation. The creator's restraint, intentional or not, means this content is less harmful than a lot of what circulates in this space. But restraint isn't the same as being informative, and 1.8 million people are drawing conclusions from imagery alone.

What should you actually know?

If you're watching transformation content and wondering whether GLP-1 medications could work for you, here's what the research actually says.

• These medications work, but not the same way for everyone. Genetic variation in GLP-1 receptor expression affects response rates, and there's no reliable way to predict your individual outcome before starting.
• Side effects are common and real. Nausea, vomiting, and gastrointestinal discomfort affect a significant portion of users, particularly in early titration phases. The STEP trials reported GI adverse events in over 40% of semaglutide users.
• Stopping the medication typically means regaining weight. This is a chronic therapy for a chronic condition, not a reset button.
• Cost and access remain serious barriers. Without insurance coverage, brand-name semaglutide and tirzepatide can exceed $1,000 per month. Compounded versions exist but are not equivalent to FDA-approved formulations, and their quality varies significantly by compounding pharmacy.
• Transformation videos, including this one, show you outcomes without context. The person in the video may have also changed their diet, exercise routine, sleep, or other factors. You're seeing a result, not a mechanism.

If you're considering GLP-1 therapy, a licensed clinician who can review your full health history is the appropriate starting point. Not TikTok.